These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 11465067)
1. Ornithine aminotransferase, a potential target for the treatment of hyperammonemias. Seiler N Curr Drug Targets; 2000 Sep; 1(2):119-53. PubMed ID: 11465067 [TBL] [Abstract][Full Text] [Related]
2. Ornithine aminotransferase activity, liver ornithine concentration and acute ammonia intoxication. Seiler N; Grauffel C; Daune G; Gerhart F Life Sci; 1989; 45(11):1009-19. PubMed ID: 2507845 [TBL] [Abstract][Full Text] [Related]
3. DL-canaline and 5-fluoromethylornithine. Comparison of two inactivators of ornithine aminotransferase. Bolkenius FN; Knödgen B; Seiler N Biochem J; 1990 Jun; 268(2):409-14. PubMed ID: 2363680 [TBL] [Abstract][Full Text] [Related]
4. Ornithine aminotransferase activity, tissue ornithine concentrations and polyamine metabolism. Seiler N; Daune G; Bolkenius FN; Knödgen B Int J Biochem; 1989; 21(4):425-32. PubMed ID: 2501116 [TBL] [Abstract][Full Text] [Related]
5. Aberrations of ammonia metabolism in ornithine carbamoyltransferase-deficient spf-ash mice and their prevention by treatment with urea cycle intermediate amino acids and an ornithine aminotransferase inactivator. Li MX; Nakajima T; Fukushige T; Kobayashi K; Seiler N; Saheki T Biochim Biophys Acta; 1999 Sep; 1455(1):1-11. PubMed ID: 10524224 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of ornithine aminotransferase by 5-fluoromethylornithine: protection against acute thioacetamide intoxication by elevated tissue ornithine levels. Seiler N; Sarhan S; Knödgen B Pharmacol Toxicol; 1992 May; 70(5 Pt 1):373-80. PubMed ID: 1608926 [TBL] [Abstract][Full Text] [Related]
7. Effects of inhibition of ornithine aminotransferase on thioacetamide-induced hepatogenic encephalopathy. Sarhan S; Knödgen B; Grauffel C; Seiler N Neurochem Res; 1993 Apr; 18(4):539-49. PubMed ID: 8474573 [TBL] [Abstract][Full Text] [Related]
8. Protection against lethal ammonia intoxication: synergism between endogenous ornithine and L-carnitine. Sarhan S; Knoedgen B; Seiler N Metab Brain Dis; 1994 Mar; 9(1):67-79. PubMed ID: 8058031 [TBL] [Abstract][Full Text] [Related]
9. Effects of ornithine aminotransferase inactivation by 5-fluoromethylornithine in rats following portacaval anastomosis. Therrien G; Sarhan S; Knödgen B; Butterworth RF; Seiler N Metab Brain Dis; 1994 Sep; 9(3):211-24. PubMed ID: 7838064 [TBL] [Abstract][Full Text] [Related]
10. Decreased hyperammonaemia and orotic aciduria due to inactivation of ornithine aminotransferase in mice with a hereditary abnormal ornithine carbamoyltransferase. Seiler N; Grauffel C; Daune-Anglard G; Sarhan S; Knödgen B J Inherit Metab Dis; 1994; 17(6):691-703. PubMed ID: 7707692 [TBL] [Abstract][Full Text] [Related]
11. 5-Fluoromethylornithine, an irreversible and specific inhibitor of L-ornithine:2-oxo-acid aminotransferase. Daune G; Gerhart F; Seiler N Biochem J; 1988 Jul; 253(2):481-8. PubMed ID: 3178724 [TBL] [Abstract][Full Text] [Related]
12. Enhanced endogenous ornithine concentrations protect against tonic seizures and coma in acute ammonia intoxication. Seiler N; Sarhan S; Knoedgen B; Hornsperger JM; Sablone M Pharmacol Toxicol; 1993 Feb; 72(2):116-23. PubMed ID: 8097310 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferase. Zielonka M; Breuer M; Okun JG; Carl M; Hoffmann GF; Kölker S PLoS One; 2018; 13(9):e0203707. PubMed ID: 30199544 [TBL] [Abstract][Full Text] [Related]
15. A new synaptosomal biosynthetic pathway of glutamate and GABA from ornithine and its negative feedback inhibition by GABA. Yoneda Y; Roberts E; Dietz GW J Neurochem; 1982 Jun; 38(6):1686-94. PubMed ID: 6122722 [TBL] [Abstract][Full Text] [Related]
16. Ornithine aminotransferase as a therapeutic target in hyperammonemias. Seiler N Adv Exp Med Biol; 1997; 420():113-42. PubMed ID: 9286430 [No Abstract] [Full Text] [Related]
17. Some biochemical and pathophysiological aspects of long-term elevation of brain ornithine concentrations. Daune-Anglard G; Bonaventure N; Seiler N Pharmacol Toxicol; 1993 Jul; 73(1):29-34. PubMed ID: 8234188 [TBL] [Abstract][Full Text] [Related]
18. Interrelationships between ornithine, glutamate, and GABA. II. Consequences of inhibition of GABA-T and ornithine aminotransferase in brain. Daune G; Seiler N Neurochem Res; 1988 Jan; 13(1):69-75. PubMed ID: 2897088 [TBL] [Abstract][Full Text] [Related]
19. Human ornithine aminotransferase complexed with L-canaline and gabaculine: structural basis for substrate recognition. Shah SA; Shen BW; Brünger AT Structure; 1997 Aug; 5(8):1067-75. PubMed ID: 9309222 [TBL] [Abstract][Full Text] [Related]
20. Endogenous ornithine in search for CNS functions and therapeutic applications. Seiler N; Daune-Anglard G Metab Brain Dis; 1993 Sep; 8(3):151-79. PubMed ID: 8272027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]